Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects

Diabetes

Volumn 52, Issue 12, 2003, Pages 2882-2887

  Tripathy, Devjit ^a   Mohanty, Priya ^a   Dhindsa, Sandeep ^a   Syed, Tufail ^a   Ghanim, Husam ^a   Aliada, Ahmad ^a   Dandona, Paresh ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Diabetes Endocrinology Center of Western New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HEPARIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MIGRATION INHIBITION FACTOR; PROTEIN SUBUNIT; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN;

ADULT; ARTICLE; BINDING AFFINITY; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MACROPHAGE; MALE; NEUTROPHIL; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; BRACHIAL ARTERY; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INFLAMMATION; INSULIN; MALE; MONOCYTES; NEUTROPHILS; NF-KAPPA B; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRANSCRIPTION FACTOR RELA; TRIGLYCERIDES; VASODILATION;

EID: 0345275811     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.12.2882     Document Type: Article

References (28)

1. Boden G, Lebed B, Schatz M, Homko C, Lemieux S: Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50:1612-1617, 2001
2. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259, 1999
3. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD: Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100:1230-1239, 1997
4. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD: Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49:1231-1238, 2000
5. Yin MJ, Yamamoto Y, Gaynor RB: The anti-inflammatory agents aspirin and sahcylate inhibit the activity of I(kappa)B kinase-beta. Nature 396:77-80, 1998
6. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293:1673-1677, 2001
7. Aljada A, Garg R, Ghanim H, Mohanty P, Hamouda W, Assian E, Dandona P: Nuclear factor-κB suppressive and inhibitor-κB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? J Endocrinol Metab 86:3250-3256, 2001
8. Aljada A, Ghanim H, Friedman J, Garg R, Mohanty P, Dandona P: Troglitazone reduces the expression of PPARγ while stimulating that of PPARα in mononuclear cells in obese subjects. J Endocrinol Metab 86:3130-3133, 2001
9. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNF alpha by human muscle: relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
10. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
11. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T: Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Endocrinol Metab 83:2907-2910, 1998
12. Dandona P, Thusu K, Hafeez R, Abdel-Rahman E, Chaudhuri A: Effect of hydrocortisone on oxygen free radical generation by mononuclear cells. Metabolism 47:788-791, 1998
13. Tosi MF, Hamedani A: A rapid, specific assay for superoxide release from phagocytes in small volumes of whole blood. Am J Clin Pathol 97:566-573, 1992
14. Hancock JT, Jones OT: The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem J 242:103-107, 1987
15. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499, 1991
16. Yagi K: Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 108:107-110, 1998
17. Perregaux D, Chaudhuri A, Rao S, Airen A, Wilson M, Sung BH, Dandona P: Brachial vascular reactivity in blacks. Hypertension 36:866-871, 2000
18. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S: Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Endocrinol Metab 86:3257-3265, 2001
19. Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K, Bucala R: Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med 1:781-788, 1995
20. Calandra T, Spiegel LA, Metz CN, Bucala R: Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci U S A 95:11383-11388, 1998
21. Boden G: Free fatty acids: the link between obesity and insulin resistance. Endocr Pract 7:44-51, 2001
22. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade. Diabetes 48:1270-1274, 1999
23. Itani SI, Ruderman NB, Schmieder F, Boden G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-2011, 2002
24. Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E, Hamouda W, Dandona P: Suppression of nuclear factor-κB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Endocrinol Metab 86:1306-1312, 2001
25. Daun JM, Cannon JG: Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα. Am J Physiol Regul Integr Comp Physiol 279:R1043-R1049, 2000
26. Vozarova B, Metz C, Stefan N, Hanson R, Lindsay S, Bucala R, Bogardus C, Tataranni A: Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia 45;1739-1741, 2002
27. Calandra T, Bernhagen J, Mitchell RA, Bucala R: The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895-1902, 1994
28. Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD: Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 96:3287-3293, 1997